← 返回

外泌体递送 7SK 长链非编码 RNA 抑制三阴性乳腺癌细胞的活力、增殖、侵袭性与致瘤性

英文原题:Exosomal delivery of 7SK long non-coding RNA suppresses viability, proliferation, aggressiveness and tumorigenicity in triple negative breast cancer cells.

查看英文原题

Exosomal delivery of 7SK long non-coding RNA suppresses viability, proliferation, aggressiveness and tumorigenicity in triple negative breast cancer cells.

PubMed 2023/04/01(内容时间) Life Sci Q1 · IF 6.4(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

高度保守的非编码RNA RN7SK(7SK)可通过与若干蛋白相互作用调节转录。尽管7SK互作蛋白促癌作用的证据不断增加,直接研究7SK与癌症关系的报告有限。本研究检验过表达7SK是否抑癌,并研究外泌体递送7SK对癌细胞表型的影响。

将人间充质干细胞来源外泌体装载7SK,处理三阴性乳腺癌MDA-MB-231细胞。以qPCR测定7SK表达,通过MTT、Annexin V/PI、凋亡相关基因检测评估活性;用生长曲线、克隆形成和细胞周期分析增殖,通过Transwell和EMT相关基因评估迁移侵袭,并用裸鼠异种移植模型评估成瘤能力。

Exo-7SK有效提高细胞内7SK表达,降低活力、增殖、迁移、侵袭和体内成瘤能力,并改变凋亡及EMT调节基因转录。Exo-7SK还降低与7SK相互作用、具有主调控及促癌作用的HMGA1及其计算筛选出的促癌靶基因mRNA水平。

概念验证结果提示,外泌体递送7SK可能通过下调HMGA1抑制癌症表型。

展开英文摘要原文

AIMS: RN7SK (7SK), a highly conserved non-coding RNA, serves as a transcription regulator via interaction with a few proteins. Despite increasing evidences which support the cancer-promoting roles of 7SK-interacting proteins, limited reports address the direct link between 7SK and cancer. To test the hypothetic suppression of cancer by overexpression of 7SK, the effects of exosomal 7SK delivery on cancer phenotypes were studied. MATERIALS AND METHODS: Exosomes derived from human mesenchymal stem cells were loaded with 7SK (Exo-7SK). MDA-MB-231, triple negative breast cancer (TNBC), cell line was treated with Exo-7sk. Expression levels of 7SK were evaluated by qPCR. Cell viability was assessed via MTT and Annexin V/PI assays as well as qPCR assessment of apoptosis-regulating genes. Cell proliferation was evaluated by growth curve analysis, colony formation and cell cycle assays. Aggressiveness of TNBCs was evaluated via transwell migration and invasion assays and qPCR assessment of genes regulating epithelial to mesenchymal transition (EMT). Moreover, tumor formation ability was assessed using a nude mice xenograft model. KEY FINDINGS: Treatment of MDA-MB-231 cells with Exo-7SK resulted in efficient overexpression of 7SK; reduced viability; altered transcription levels of apoptosis-regulating genes; reduced proliferation; reduced migration and invasion; altered transcription of EMT-regulating genes; and reduced in vivo tumor formation ability. Finally, Exo-7SK reduced mRNA levels of HMGA1, a 7SK interacting protein with master gene regulatory and cancer promoting roles, and its bioinformatically-selected cancer promoting target genes. SIGNIFICANCE: Altogether, as a proof of the concept, our findings suggest that exosomal delivery of 7SK may suppress cancer phenotypes via downregulation of HMGA1.

论文信息

作者
Farhadi S、Mohammadi-Yeganeh S、Kiani J、Hashemi SM、Koochaki A、Sharifi K、Ghanbarian H
第一作者单位
Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.Iran
通讯作者单位
Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Medical Nanotechnology and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: hghanbarian@sbmu.ac.ir.Iran
期刊
Life sciences2023 Jun 1
原文标识
PubMed 37011870 · DOI 10.1016/j.lfs.2023.121646